European Healthtech startup funding raised during Q3 2017.
In Q3 2017, 110 European Healthtech companies raised a combined €1.5B across 112 funding rounds, up 216.4% versus Q3 2016. Switzerland led by capital raised, and Seventure Partners was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Growth/Late | Aug 2017 | €938M |
| Nightstar | Series C | Jul 2017 | €39M |
| Sophia Genetics | Series D+ | Jul 2017 | €26M |
| NicOx | Other | Sep 2017 |
9 exits · €112M disclosed.
| VisionSense | Acquisition | Sep 2017 | €68M |
| iSalud | Acquisition | Sep 2017 | €30M |
| Vitalsana | Acquisition | Sep 2017 | €14M |
| €26M |
| GenSight Biologics | Other | Sep 2017 | €23M |
| Push Doctor | Series B | Jul 2017 | €22M |
| Ieso | Other | Aug 2017 | €20M |
| Eligo Bioscience | Series A | Sep 2017 | €17M |
| Sparingvision | Other | Jul 2017 | €16M |
| Bioserenity | Series A | Aug 2017 | €15M |
| Kuros | Other | Sep 2017 | €15M |
| Simba Sleep | Other | Sep 2017 | €15M |
| Blueprint Genetics | Series A | Aug 2017 | €14M |
| Diabeloop | Other | Sep 2017 | €14M |
| Magenta Medical | Series B | Jul 2017 | €13M |
